Search

everythinglearnresearchcommunity

for

Search:↓

Hirsutism, excessive hair growth in women, is often caused by PCOS and can be managed with medication and personalized treatment plans.

Female pattern hair loss involves thinning hair on crown and frontal scalp, diagnosed by hair ratio, and treated with minoxidil, antiandrogens, or hair transplantation.

Hair loss in Androgenetic alopecia (AGA) is due to altered cell sensitivity to hormones, not increased hormone levels. Hair growth periods shorten over time, causing hair to become thinner and shorter. This is linked to miscommunication between cell pathways in hair follicles. There's also a change in gene expression related to blood vessels and cell growth in balding hair follicles. The exact molecular causes of AGA are still unclear.

Exosomes from stem cells help hair regrowth by activating a specific signaling pathway.

The conclusion is that oral contraceptives and antiandrogens can treat hirsutism and acne in women with cutaneous hyperandrogenism, but more research is needed for effective treatments, especially for hair loss.

Patients with PCOS tend to score their hirsutism higher than clinicians, making self-scoring less useful for diagnosis.

Androgens, like testosterone, are crucial for early testicular descent in rats.

Androgenic Alopecia, a common hair loss condition, can be effectively treated with finasteride and other treatments.

Medicines that lower androgen levels and hair removal treatments help manage excessive hair and acne in women with PCOS.

RE-ORGA, a Korean herb extract, may help prevent hair loss.

The document concluded that more research is needed to understand how estrogen affects the enzyme involved in hirsutism development.

The document concludes that more multidisciplinary research is needed to understand and treat PCOS, a condition that significantly affects women's health and quality of life.

Reduced alpha smooth muscle actin may cause hair loss in androgenetic alopecia.

Detailed history and physical examination are crucial for diagnosing hair loss.

DHEA stimulates skin oil glands and could help postmenopausal women, with potential for acne and excessive hair growth treatments.

Natural 5AR inhibitors effectively improve mild to moderate hair loss in men.

Plant extracts effectively reduce hair loss and increase growth, offering a safe alternative treatment.

Some plant-derived compounds may help with hormonal conditions, but more research is needed to confirm their effectiveness.

The document concludes that managing hirsutism involves identifying the cause, using a scoring system for severity, combining cosmetic and medical treatments, encouraging weight loss, and providing psychological support, while noting the need for more research on drug treatments.

A new plant extract from Avicennia marina could potentially be used to treat common hair loss.

New cell-based therapies may improve hair loss treatments in the future.

Finasteride and minoxidil are effective for hair regrowth, while treatments for alopecia areata have varying success and continuous treatment is necessary.

Compounds from Angelica koreana roots, especially osthenol, could be effective for treating conditions like prostate disease and hair loss.

Phyto-vesicles of β-sitosterol may effectively treat hair loss.

Preventing hair loss is more effective than regrowth; oral finasteride is a realistic option.

The supplement with Serenoa repens and Pygeum africanum significantly increased active hair growth and decreased rest phase hair in post-menopausal women with hair loss, with only mild digestive side effects.

Using scalp stem cells can improve hair transplants.

Androgens prevent hair growth by changing Wnt signals in cells.

Hormonal therapy is a treatment option for acne, the only medical treatment for hirsutism, and the most promising for androgenetic alopecia.

FPHL causes hair loss in women due to genetics and hormones; minoxidil and anti-androgens are treatments, and early intervention is advised.